Tag: Medicines Australia

No consultations on R&D tax changes

Posted on   |  by Denham Sadler
The government did not undertake any consultation on its planned $1.8 billion cut to the R&D tax incentive, with the reintroduction of the significant changes taking major stakeholders by...

Biotech industry: RDTI is ‘critical’

Posted on   |  by James Riley
The leaders of seven Australian health and biotech industry groups have joined forces to press both sides of politics to preserve and strengthen support of research and development. In...